System Transmission

Top Signal

100#1 JOB

Activity

2170Ripe

+926 today

System

Livenow

Terminal Asset View

stockNASDAQ

PGEN

$3.51+7.01%

Precigen Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

7Overripe

Live Analysis Active

Company Mission

Precigen Inc creates gene and cell therapies, which are treatments that work by modifying genes or using living cells to fight diseases. Their technologies target serious conditions like cancer and rare genetic disorders. The company makes money through partnerships with other research organizations, licensing its technology to pharmaceutical companies, and advancing its own therapies through clinical trials toward potential approval.

PGE

Industry Context

The biotechnology industry focuses on using living systems to develop treatments for diseases. Companies in this space research new therapies, often for serious conditions like cancer, and work to get them approved by regulators. Gene and cell therapy is a growing area within biotech that aims to treat diseases by modifying genes or using living cells as medicine.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

25Matrix

Market Momentum

41.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

7.01%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing PGEN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:29 PM UTC

As-of 03-14-2026 19:13 UTC

Develops gene therapies for rare diseases and makes money by licensing its treatments to pharmaceutical companies.

Price consolidated in a tight range for several weeks, suggesting energy building for the next significant move showing consolidation pattern.

Biotech sector showing renewed interest in gene editing platforms, which could benefit companies with advanced technology like this one.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...